Crigler-Najjar Syndrome Type 2
Article Outline
Crigler-Najjar syndrome is a rare disorder of bilirubin metabolism with two distinct forms: type 1 and type 2. We report three patients with Crigler-Najjar syndrome type 2 (CN-2). All patients had serum bilirubin values higher than 171 μmol/L and deep yellow skin color. The results of other liver function tests, glucose-6-phosphate dehydrogenase activity and hematology tests were normal, and immunologic tests for hepatitis A, B and C were negative, although one patient had slightly elevated alanine aminotransferase level (45 IU/L). Polymerase chain reaction and sequence analysis of the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene revealed a novel homozygous T > A mutation at nucleotide 479 in exon 1 (Val160Glu) of patient 1, a novel homozygous A >G mutation at nucleotide 610 in exon 1 (Met204Val) of patient 2, and a homozygous T >G variation at nucleotide 1456 in exon 5 (Tyr486Asp) plus a heterozygous G > A variation at nucleotide 211 in exon 1 (Gly71 Arg/normal) of patient 3. Two of these mutations were novel and variations identified within the coding region of the UGT1A1 gene were considered the cause of CN-2 in all three patients.
Key Words: Crigler-Najjar syndrome , glucuronosyltransferase , novel mutation
No full text is available. To read the body of this article, please view the PDF online.
References
- Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltrans-ferase (UGT1A1) causing Crigler-Najjar and Gilbert's syndromes: correlation of genotype to phenotype . Hum Mutat . 2000;16:297–306
- Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II . Biochem Biophys Acta . 1998;1406:267–273
- . Delayed response to pheno-barbital treatment of a Crigler-Najjar type 2 patient with partially inactivating missense mutations in the bilirubin UDP-glucuronosyltransferase gene . J Pediatr Gastroenterol Nutrit . 1999;28:210–213
- Analysis of biliru-bin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutation in seven patients with Crigler-Najjar syndrome type II . J Hum Genet . 1998;43:111–114
- Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyl-transferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects . J Gastroenterol Hepatol . 2004;19:1023–1028
- A novel compound heterozygous variation of the uridine-diphosphoglucuronosyl transferase 1A1 gene that causes Crigler-Najjar syndrome type II . Pharmacogenetics . 2001;11:639–642
- Co-occurrence of three different mutations in the bilirubin UDP-glucuronosyltrans-ferase gene in a Chinese family with Crigler-Najjar syndrome type I and Gilbert's syndrome . Clin Genet . 2003;64:420–423
- Severe hyperbilirubi-naemia in a Chinese girl with type I Crigler-Najjar syndrome. First case ever reported in Mainland China . J Paediatr Child Health . 2005;41:300–302
- Crigler-Najjar syndrome type II resulting from three different mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene . J Med Genet . 2000;37:712–713
- Association of a homozy-gous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome . Hum Mutat . 2002;20:399–401
- Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation . Hum Mutat . 2005;25:325–333
- Variations of the biliru-bin uridine-diphosphoglucuronosyl transferase 1A1 gene in healthy Taiwanese . Pharmacogenetics . 2000;10:539–544
- Correlation of mutation analysis to clinical features in Taiwanese patients with Gilbert's syndrome . Am J Gastroenterology . 2001;96:1188–1193
- Genetic factors related to unconjugated hyperbilirubinemia amongst adults . Phar-macogenet Genomics . 2005;15:43–50
- . Molecular genetics of unconjugated hyper-bilirubinemia in Taiwanese . J Biomed Sci. . 2005;12:445–450
PII: S0929-6646(09)60182-0
doi:10.1016/S0929-6646(09)60182-0
© 2006 Formosan Medical Association & Elsevier. Published by Elsevier Inc. All rights reserved.
